MIGUEL YEBRA, M.D.; JAVIER SEGOVIA, M.D.; LUIS MANZANO, M.D.; JUAN A. VARGAS, M.D.; LUIS BERNALDO DE QUIRÓS; JORGE ALVAR, M.D.
To the editor: In our letter in the March issue (1), a point should be modified. In the sentence, "Their [parasites] presence in clinically unaffected skin is unprecedented," the last word should be changed to "exceptional." Thus, visceral leishmaniasis with cutaneous dissemination should be included among indicator diseases in section Ha of the 1987 revision of the Centers for Disease Control's Surveillance Case Definition for acquired immunodeficiency syndrome (2), instead of section Ib as formerly proposed.
In any case, these changes are irrelevant to the practical concerns of the physician who deals with these diseases.
YEBRA M, SEGOVIA J, MANZANO L, VARGAS JA, DE QUIRÓS LB, ALVAR J. Kala-Azar and the Acquired Immunodeficiency Syndrome (AIDS). Ann Intern Med. ;108:906. doi: 10.7326/0003-4819-108-6-906_2
Download citation file:
Published: Ann Intern Med. 1988;108(6):906.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use